Free Trial

Trellus Health (TRLS) Competitors

GBX 0.75 -0.08 (-9.09%)
As of 10/16/2025 11:34 AM Eastern

TRLS vs. FDBK, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COG

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

In the previous week, Feedback had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for Feedback and 0 mentions for Trellus Health. Feedback's average media sentiment score of 1.36 beat Trellus Health's score of 0.00 indicating that Feedback is being referred to more favorably in the media.

Company Overall Sentiment
Feedback Positive
Trellus Health Neutral

Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£885.62K5.19-£10.84M-£0.26-41.18
Trellus Health£359K3.37-£7.98M-£0.05-15.00

Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -39.71% -22.99%
Trellus Health -12,114.55%-37.95%-22.76%

Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, suggesting that its stock price is 99% less volatile than the S&P 500.

36.6% of Feedback shares are owned by institutional investors. Comparatively, 5.8% of Trellus Health shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Comparatively, 21.5% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Feedback beats Trellus Health on 7 of the 13 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRLS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.21M£358.52M£6.08B£2.55B
Dividend YieldN/A5.90%5.73%5.32%
P/E Ratio-15.00495.8684.564,378.30
Price / Sales3.37251.49596.7699,719.20
Price / Cash0.7647.1437.8627.90
Price / Book0.085.0612.388.19
Net Income-£7.98M-£15.55M£3.32B£5.89B
7 Day Performance-11.76%-1.56%2.25%-0.79%
1 Month Performance32.74%2.36%9.62%1.15%
1 Year Performance19.05%15.57%73.83%138.35%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.75
-9.1%
N/A+0.3%£1.21M£359K-15.0031Gap Down
FDBK
Feedback
N/AGBX 10.20
-1.4%
N/A-81.6%£4.53M£885.62K-40.0024
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-28.9%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.555 of 5 stars
GBX 2,320
-2.9%
GBX 2,873.67
+23.9%
+21.9%£846.29M£205.66M4,202.90734Gap Down
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
1.4704 of 5 stars
GBX 142.22
-0.9%
GBX 365
+156.6%
-50.4%£51.68M£66.34M1,777.75478
RENX
Renalytix
N/AGBX 9.27
+3.0%
N/A+13.9%£36.48M£2.37M-57.94102Positive News
Gap Up
High Trading Volume
COG
Cambridge Cognition
N/AGBX 34.70
+0.6%
N/A+24.6%£16.06M£9.05M-913.1680News Coverage
High Trading Volume

Related Companies and Tools


This page (LON:TRLS) was last updated on 10/17/2025 by MarketBeat.com Staff
From Our Partners